HYTN Announces Closing of Non-Brokered Private Placement Under Listed Issuer Financing Exemption
October 26, 2023 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Oct. 26, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (the “Company” or “HYTN”) (CSE: HYTN) is pleased to announce that it has closed its previously announced...
HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine
March 02, 2023 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a Vancouver-based company specializing in the production of psychoactive...
HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development
February 23, 2023 08:40 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announced that it has successfully initiated cultivation of psilocybin...
HYTN Innovations Advances Active Pharmaceutical Ingredient Portfolio and Increases Sales of Rapid Onset Cannabis Products Using Proprietary Elevation Technology
February 16, 2023 08:54 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Feb. 16, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a leading manufacturer of products containing psychoactive and...
HYTN Sells Out of Innovative Holiday Products
November 30, 2022 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Nov. 30, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) announces that its wholly owned subsidiary, HYTN Cannabis Inc., has...
HYTN Initiates Sale of Cannabis Products in Quebec Through Agreement With Rose
October 24, 2022 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis...
HYTN Awarded Controlled Drugs and Substances Dealer’s License Allowing for Production and Sale of Psilocybin
October 17, 2022 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Oct. 17, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN), a leading cannabis company focused on creating consistent, natural and...
HYTN Opens Provincial and Territorial Markets for Tricanna Manufactured Pre-Rolled Cannabis Products
September 29, 2022 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis...
HYTN Announces Launch of Rapid Onset Nano Gummies and Provides Commercial Update
August 29, 2022 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that, through its wholly owned subsidiary, HYTN...
HYTN Awarded Medical Cannabis Sales Licence Increasing Opportunities at Kelowna Facility
August 23, 2022 08:00 ET
|
HYTN Innovations Inc.
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis...